Cargando…
Evaluation of a simplified optimizer for MR‐guided adaptive RT in case of pancreatic cancer
PURPOSE: Magnetic resonance‐guided adaptive radiotherapy (MRgART) is considered a promising resource for pancreatic cancer, as it allows to online modify the dose distribution according to daily anatomy. This study aims to compare the dosimetric performance of a simplified optimizer implemented on a...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753732/ https://www.ncbi.nlm.nih.gov/pubmed/31444952 http://dx.doi.org/10.1002/acm2.12697 |
_version_ | 1783452950137405440 |
---|---|
author | Cusumano, Davide Boldrini, Luca Menna, Sebastiano Teodoli, Stefania Placidi, Elisa Chiloiro, Giuditta Placidi, Lorenzo Greco, Francesca Stimato, Gerardina Cellini, Francesco Valentini, Vincenzo Azario, Luigi De Spirito, Marco |
author_facet | Cusumano, Davide Boldrini, Luca Menna, Sebastiano Teodoli, Stefania Placidi, Elisa Chiloiro, Giuditta Placidi, Lorenzo Greco, Francesca Stimato, Gerardina Cellini, Francesco Valentini, Vincenzo Azario, Luigi De Spirito, Marco |
author_sort | Cusumano, Davide |
collection | PubMed |
description | PURPOSE: Magnetic resonance‐guided adaptive radiotherapy (MRgART) is considered a promising resource for pancreatic cancer, as it allows to online modify the dose distribution according to daily anatomy. This study aims to compare the dosimetric performance of a simplified optimizer implemented on a MR‐Linac treatment planning system (TPS) with those obtained using an advanced optimizer implemented on a conventional Linac. METHODS: Twenty patients affected by locally advanced pancreatic cancer (LAPC) were considered. Gross tumor volume (GTV) and surrounding organ at risks (OARs) were contoured on the average 4DCT scan. Planning target volume was generated from GTV by adding an isotropic 3 mm margin and excluding overlap areas with OARs. Treatment plans were generated by using the simple optimizer for the MR‐Linac in intensity‐modulated radiation therapy (IMRT) and the advanced optimizer for conventional Linac in IMRT and volumetric modulated arc therapy (VMAT) technique. Prescription dose was 40 Gy in five fractions. The dosimetric comparison was performed on target coverage, dosimetric indicators, and low dose diffusion. RESULTS: The simplified optimizer of MR‐Linac generated clinically acceptable plans in 80% and optimal plans in 55% of cases. The number of clinically acceptable plans obtained using the advanced optimizer of the conventional Linac with IMRT was the same of MR‐Linac, but the percentage of optimal plans was higher (65%). Using the VMAT technique, it is possible to obtain clinically acceptable plan in 95% and optimal plans in 90% of cases. The advanced optimizer combined with VMAT technique ensures higher target dose homogeneity and minor diffusion of low doses, but its actual optimization time is not suitable for MRgART. CONCLUSION: Simplified optimization solutions implemented in the MR‐Linac TPS allows to elaborate in most of cases treatment plans dosimetrically comparable with those obtained by using an advanced optimizer. A superior treatment plan quality is possible using the VMAT technique that could represent a breakthrough for the MRgART if the modern advancements will lead to shorter optimization times. |
format | Online Article Text |
id | pubmed-6753732 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-67537322019-09-23 Evaluation of a simplified optimizer for MR‐guided adaptive RT in case of pancreatic cancer Cusumano, Davide Boldrini, Luca Menna, Sebastiano Teodoli, Stefania Placidi, Elisa Chiloiro, Giuditta Placidi, Lorenzo Greco, Francesca Stimato, Gerardina Cellini, Francesco Valentini, Vincenzo Azario, Luigi De Spirito, Marco J Appl Clin Med Phys Radiation Oncology Physics PURPOSE: Magnetic resonance‐guided adaptive radiotherapy (MRgART) is considered a promising resource for pancreatic cancer, as it allows to online modify the dose distribution according to daily anatomy. This study aims to compare the dosimetric performance of a simplified optimizer implemented on a MR‐Linac treatment planning system (TPS) with those obtained using an advanced optimizer implemented on a conventional Linac. METHODS: Twenty patients affected by locally advanced pancreatic cancer (LAPC) were considered. Gross tumor volume (GTV) and surrounding organ at risks (OARs) were contoured on the average 4DCT scan. Planning target volume was generated from GTV by adding an isotropic 3 mm margin and excluding overlap areas with OARs. Treatment plans were generated by using the simple optimizer for the MR‐Linac in intensity‐modulated radiation therapy (IMRT) and the advanced optimizer for conventional Linac in IMRT and volumetric modulated arc therapy (VMAT) technique. Prescription dose was 40 Gy in five fractions. The dosimetric comparison was performed on target coverage, dosimetric indicators, and low dose diffusion. RESULTS: The simplified optimizer of MR‐Linac generated clinically acceptable plans in 80% and optimal plans in 55% of cases. The number of clinically acceptable plans obtained using the advanced optimizer of the conventional Linac with IMRT was the same of MR‐Linac, but the percentage of optimal plans was higher (65%). Using the VMAT technique, it is possible to obtain clinically acceptable plan in 95% and optimal plans in 90% of cases. The advanced optimizer combined with VMAT technique ensures higher target dose homogeneity and minor diffusion of low doses, but its actual optimization time is not suitable for MRgART. CONCLUSION: Simplified optimization solutions implemented in the MR‐Linac TPS allows to elaborate in most of cases treatment plans dosimetrically comparable with those obtained by using an advanced optimizer. A superior treatment plan quality is possible using the VMAT technique that could represent a breakthrough for the MRgART if the modern advancements will lead to shorter optimization times. John Wiley and Sons Inc. 2019-08-24 /pmc/articles/PMC6753732/ /pubmed/31444952 http://dx.doi.org/10.1002/acm2.12697 Text en © 2019 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Radiation Oncology Physics Cusumano, Davide Boldrini, Luca Menna, Sebastiano Teodoli, Stefania Placidi, Elisa Chiloiro, Giuditta Placidi, Lorenzo Greco, Francesca Stimato, Gerardina Cellini, Francesco Valentini, Vincenzo Azario, Luigi De Spirito, Marco Evaluation of a simplified optimizer for MR‐guided adaptive RT in case of pancreatic cancer |
title | Evaluation of a simplified optimizer for MR‐guided adaptive RT in case of pancreatic cancer |
title_full | Evaluation of a simplified optimizer for MR‐guided adaptive RT in case of pancreatic cancer |
title_fullStr | Evaluation of a simplified optimizer for MR‐guided adaptive RT in case of pancreatic cancer |
title_full_unstemmed | Evaluation of a simplified optimizer for MR‐guided adaptive RT in case of pancreatic cancer |
title_short | Evaluation of a simplified optimizer for MR‐guided adaptive RT in case of pancreatic cancer |
title_sort | evaluation of a simplified optimizer for mr‐guided adaptive rt in case of pancreatic cancer |
topic | Radiation Oncology Physics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753732/ https://www.ncbi.nlm.nih.gov/pubmed/31444952 http://dx.doi.org/10.1002/acm2.12697 |
work_keys_str_mv | AT cusumanodavide evaluationofasimplifiedoptimizerformrguidedadaptivertincaseofpancreaticcancer AT boldriniluca evaluationofasimplifiedoptimizerformrguidedadaptivertincaseofpancreaticcancer AT mennasebastiano evaluationofasimplifiedoptimizerformrguidedadaptivertincaseofpancreaticcancer AT teodolistefania evaluationofasimplifiedoptimizerformrguidedadaptivertincaseofpancreaticcancer AT placidielisa evaluationofasimplifiedoptimizerformrguidedadaptivertincaseofpancreaticcancer AT chiloirogiuditta evaluationofasimplifiedoptimizerformrguidedadaptivertincaseofpancreaticcancer AT placidilorenzo evaluationofasimplifiedoptimizerformrguidedadaptivertincaseofpancreaticcancer AT grecofrancesca evaluationofasimplifiedoptimizerformrguidedadaptivertincaseofpancreaticcancer AT stimatogerardina evaluationofasimplifiedoptimizerformrguidedadaptivertincaseofpancreaticcancer AT cellinifrancesco evaluationofasimplifiedoptimizerformrguidedadaptivertincaseofpancreaticcancer AT valentinivincenzo evaluationofasimplifiedoptimizerformrguidedadaptivertincaseofpancreaticcancer AT azarioluigi evaluationofasimplifiedoptimizerformrguidedadaptivertincaseofpancreaticcancer AT despiritomarco evaluationofasimplifiedoptimizerformrguidedadaptivertincaseofpancreaticcancer |